Bromide

Bromide

SCHEMBL194547

CCCC[n+]1cccc(C)c1.[Br-]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.52
CHRM4 known ✓ P08173 1/20 0.52
CHRM5 known ✓ P08912 1/20 0.52
CHRM1 known ✓ P11229 1/20 0.52
CHRM3 known ✓ P20309 1/20 0.52
ACHE known ✓ P22303 1/20 0.52
HTT P42858 4/20 0.55
LMNA P02545 4/20 0.52
RAD52 P43351 2/20 0.52
HSP90AA1 P07900 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
EGFR P00533 1/20 0.52
PLA2G1B P04054 1/20 0.52
ERBB2 P04626 1/20 0.52
LCK P06239 1/20 0.52
FYN P06241 1/20 0.52
ADRA2A P08913 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL17926315 1.00 HTT (0.55) HTTLMNARAD52HSP90AA1SMN1; SMN2
Bromide SCHEMBL29987617 1.00 HTT (0.55) HTTLMNARAD52HSP90AA1SMN1; SMN2
Bromide SCHEMBL17926316 0.98 HTT (0.53) HTTLMNARAD52HSP90AA1SMN1; SMN2
SCHEMBL296028 0.98 HTT (0.57) HTTLMNARAD52CHRM2ADRA2A
SCHEMBL29394041 0.98 HTT (0.57) HTTLMNARAD52CHRM2ADRA2A
Hydrochloric Acid SCHEMBL17926382 0.96 HTT (0.55) HTTLMNARAD52HSP90AA1SMN1; SMN2
Hydrochloric Acid SCHEMBL29465194 0.96 HTT (0.55) HTTLMNARAD52HSP90AA1SMN1; SMN2
Iodide SCHEMBL16107451 0.96 HTT (0.55) HTTLMNARAD52SMN1; SMN2CHRM2
Fluoride Ion SCHEMBL30213090 0.96 HTT (0.55) HTTLMNARAD52CHRM2ADRA2A
Water SCHEMBL15375382 0.96 HTT (0.55) HTTLMNARAD52CHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976234-B1 QUATERNARY AMMONIUM HALIDES FOR TREATING HALOGEN CONTAMINATION BROMINE COMPOUNDS LTD (IL) 2026-05-27 EP claimed
US-20260078235-A1 METHOD FOR POLYURETHANE DEPOLYMERIZATION UNIV MURCIA (ES) 2026-03-19 US claimed
CN-117126654-B Blocking remover, preparation method, use method and application 中国石油天然气股份有限公司 2025-05-23 CN claimed
EP-4556514-A1 METHOD FOR POLYURETHANE DEPOLYMERIZATION Universidad de Murcia (ES) 2025-05-21 EP claimed
CN-114566723-B Electrolyte for rechargeable electrochemical cells EOS能源技术控股有限责任公司 2025-03-04 CN claimed
US-20240342530-A1 QUARTERNARY AMMONIUM HALIDES FOR TREATING HALOGEN CONTAMINATION BROMINE COMPOUNDS LTD (IL) 2024-10-17 US claimed
CN-117839636-B Treatment agent and treatment method for eutrophic cultivation wastewater 金满塘(天津)生物科技有限公司 2024-05-07 CN claimed
CN-117839636-A Treatment agent and treatment method for eutrophic cultivation wastewater 金满塘(天津)生物科技有限公司 2024-04-09 CN claimed
CN-114007703-B Quaternary ammonium halides for treating halogen pollution 溴化合物有限公司 2024-03-22 CN claimed
EP-4315482-A1 HALOGEN COMPLEXING AGENTS BOUND TO THE CATHODE SURFACE IN A STATIC ZINC HALIDE BATTERY EOS Energy Technology Holdings, LLC (US) 2024-02-07 EP claimed
CN-105026371-A Process for preparing 1-alkyl-3-alkyl-pyridinium bromides and their use as additives in electrochemical cells BROMINE COMPOUNDS LTD 2015-11-04 CN claimed
EP-2934469-A2 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS Colgate-Palmolive Company (US) 2015-10-28 EP claimed
WO-2015125095-A1 PROCESS FOR OXIDATION OF ALKYL AROMATIC COMPOUND TO AROMATIC CARBOXYLIC ACID RELIANCE INDUSTRIES LIMITED (IN) 2015-08-27 WO claimed
WO-2014122641-A1 PROCESSES FOR PREPARING L-ALKYL-3-ALKYL-PYRIDINIUM BROMIDE AND USES THEREOF AS ADDITIVES IN ELECTROCHEMICAL CELLS BROMINE COMPOUNDS LTD. (IL) 2014-08-14 WO claimed
WO-2014098871-A2 ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS COLGATE-PALMOLIVE COMPANY (US) 2014-06-26 WO claimed
EP-2195295-B1 METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM HANMI SCIENCE CO LTD (KR) 2013-01-23 EP claimed
US-8217100-B2 Adhesive composition and optical member CHEIL INDUSTRIES, INC. (KR) 2012-07-10 US claimed
EP-2195295-A1 METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM Hanmi Pharm. Co., Ltd. (KR) 2010-06-16 EP claimed
WO-2009048236-A1 METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM HANMI PHARM. CO., LTD. (KR) 2009-04-16 WO claimed
US-20090014123-A1 Adhesive composition and optical member Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) 2009-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078235-A1 METHOD FOR POLYURETHANE DEPOLYMERIZATION FGB, POLR2B, POLB CHRM2 3826/4885CHRM4 4538/4885CHRM5 4177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.